Skip to content

Evaluation of efficacy of Exicilia topical serum in eyebrow hypotrichosis

Evaluation of efficacy and safety of Exicilia topical serum(bimatoprost 0.03) for improvement of eyebrow hypotrichosis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150101020514N9
Enrollment
22
Registered
2020-08-24
Start date
2020-08-22
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotrichosis.

Interventions

Intervention group: 16 weeks treatment using topical Exicilia serum (containing 0.03% bimatoprost) manufactured by CinnaGen company, once daily.

Sponsors

CinnaGen Co.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged between 18 to 60 years eyebrow hypotrichosis grade 1 or 2 according to GEBA Scoring Signing consent form

Exclusion criteria

Exclusion criteria: Having alopecia areata Permanent tattoos, moles, scars or any damage to the eyebrows that interferes with assessments fillers injection in the eyebrow area in the past year Eyebrow extensions in the last 3 months Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Percentage of people with one grade or more improvement in GEBA scale. Timepoint: Before intervention and 8 and 16 weeks after intervention. Method of measurement: Scoring eyebrow thickness using digital photos based on Allergan Global Eyebrow assessment (GEBA).

Secondary

MeasureTime frame
Patient satisfaction from treatment. Timepoint: 16 and 24 weeks after intervention. Method of measurement: Using a 6-point Likert scale.;Comparison of eyebrow hair count. Timepoint: Before intervention and 16 and 24 weeks after intervention. Method of measurement: Trichoscan.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8897 8190

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026